Ocera Therapeutics, Inc. Operating Income
Ocera Therapeutics, Inc. reported Operating Income of -$2.48 million for the 3-month period ending 2013-06-30, per its 10-Q filed 2013-08-14.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2013-08-14
- Ocera Therapeutics, Inc. operating income (loss) for the quarter ending 2013-06-30 was -$2.48M.
- Ocera Therapeutics, Inc. operating income (loss) for the quarter ending 2013-03-31 was -$3.39M.
- Ocera Therapeutics, Inc. operating income (loss) for the quarter ending 2012-12-31 was -$3.04M.
- Ocera Therapeutics, Inc. operating income (loss) for the quarter ending 2012-09-30 was -$3.57M.
- Ocera Therapeutics, Inc. operating income (loss) for fiscal 2012 was -$19.09M.
- Ocera Therapeutics, Inc. operating income (loss) for fiscal 2011 was -$20.75M.
- Ocera Therapeutics, Inc. operating income (loss) for fiscal 2010 was -$5.42M.
- Ocera Therapeutics, Inc. operating income (loss) for fiscal 2009 was -$9.98M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2013-06-30 | -$2.48M 10-Q · filed 2013-08-14 | -$5.87M 10-Q · filed 2013-08-14 | -$8.91M derived: sum of 3 quarters · filed 2013-08-14 | -$12.48M derived: sum of 4 quarters · filed 2013-08-14 |
| 2013-03-31 | -$3.39M 10-Q · filed 2013-05-14 | -$6.43M derived: sum of 2 quarters · filed 2013-05-14 | -$10.00M derived: sum of 3 quarters · filed 2013-05-14 | -$15.01M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-12-31 | -$3.04M 10-K · filed 2013-03-28 | -$6.61M derived: sum of 2 quarters · filed 2013-03-28 | -$11.61M derived: sum of 3 quarters · filed 2013-08-14 | -$19.09M 10-K · filed 2013-03-28 |
| 2012-09-30 | -$3.57M 10-K · filed 2013-03-28 | -$8.57M derived: sum of 2 quarters · filed 2013-08-14 | -$16.05M 10-Q · filed 2012-11-09 | -$23.68M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-06-30 | -$5.00M 10-Q · filed 2013-08-14 | -$12.48M 10-Q · filed 2013-08-14 | -$20.11M derived: sum of 3 quarters · filed 2013-08-14 | -$26.10M derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | -$7.48M 10-Q · filed 2013-05-14 | -$15.11M derived: sum of 2 quarters · filed 2013-05-14 | -$21.10M derived: sum of 3 quarters · filed 2013-05-14 | -$25.09M derived: sum of 4 quarters · filed 2013-05-14 |
| 2011-12-31 | -$7.63M 10-K · filed 2013-03-28 | -$13.62M derived: sum of 2 quarters · filed 2013-03-28 | -$17.61M derived: sum of 3 quarters · filed 2013-03-28 | -$20.75M 10-K · filed 2013-03-28 |
| 2011-09-30 | -$5.99M 10-K · filed 2013-03-28 | -$9.98M derived: sum of 2 quarters · filed 2013-03-28 | -$13.12M 10-Q · filed 2012-11-09 | -$13.57M derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-06-30 | -$4.00M 10-K · filed 2013-03-28 | -$7.13M 10-Q · filed 2012-08-10 | -$7.58M derived: sum of 3 quarters · filed 2013-03-28 | -$8.71M derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-03-31 | -$3.13M 10-K · filed 2013-03-28 | -$3.59M derived: sum of 2 quarters · filed 2013-03-28 | -$4.71M derived: sum of 3 quarters · filed 2013-03-28 | -$6.18M derived: sum of 4 quarters · filed 2013-03-28 |
| 2010-12-31 | -$456.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$1.58M derived: sum of 2 quarters · filed 2013-03-28 | -$3.04M derived: sum of 3 quarters · filed 2013-03-28 | -$5.42M 10-K · filed 2013-03-28 |
| 2010-09-30 | -$1.13M 10-Q · filed 2011-11-10 | -$2.59M derived: sum of 2 quarters · filed 2011-11-10 | -$4.96M 10-Q · filed 2011-11-10 | |
| 2010-06-30 | -$1.46M 10-Q · filed 2011-08-11 | -$3.83M 10-Q · filed 2011-08-11 | ||
| 2009-12-31 | -$9.98M 10-K · filed 2012-02-29 |